hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Aspen to market last-resort Aids drug across Africa

Author: Samantha Enslin, Business Report [So. Africa], Published on: 5 April 2007

Aspen plans to market a salvage treatment, Prezista, for Aids patients in 20 sub-Saharan African countries through a deal with Ireland's Tibotec Pharmaceuticals [a division of Johnson & Johnson (J&J)]...The deal was structured so that Aspen would market Prezista...on a cost recovery basis...Tibotec…will not earn anything...Salvage treatment is a last resort for Aids patients…[Senior executive of Aspen] Nicolaou, said: "In Africa only about 20 percent to 25 percent of the 6 million Africans who require treatment are receiving it…"...

Read the full post here

Related companies: Aspen Pharmacare Johnson & Johnson Tibotec (part of Johnson & Johnson)